This test is most useful if any of these apply to you.
If you're a man with a fading sex drive, flat energy, or muscle that won't come back, total testosterone is the number that tells you whether low hormones could be part of the story. If you're a woman with irregular periods, acne, or hair growing where you don't want it, it's one of the first checks for too much male hormone. In both cases it's a routine blood test you can order yourself.
In large studies, men with low testosterone have weaker bones, less muscle, and higher death rates, though researchers still disagree about how much of that the hormone itself causes. The way it's measured also matters. This version of the test uses an immunoassay, which reads adult male levels reasonably well but gets less accurate at the low levels found in women, children, and some men who are seriously ill.
Testosterone is a steroid hormone your body builds from cholesterol. In men it comes mostly from the testes, which make it in response to a pituitary signal called luteinizing hormone (LH), with a small amount from the adrenal glands. In women it comes from direct ovarian and adrenal production plus conversion of precursor hormones in tissues such as fat and liver; many reviews estimate that conversion supplies about half and the rest is split between the ovaries and adrenal glands.
Very little floats freely in the blood. About 43% to 45% is held tightly by sex hormone-binding globulin (SHBG). About 50% to 55% is held loosely by albumin. Albumin is the most common protein in blood. Only 1% to 4% is free. The free and loosely held portions are the ones your tissues can use.
A total testosterone test adds all three portions together, so anything that changes SHBG changes the total even if the usable amount stays the same. Obesity and insulin resistance lower SHBG, which means the total can look low while free testosterone is normal. In many older men SHBG goes up, so a total inside the expected range can hide a free level that's too low.
An immunoassay uses antibodies that latch onto testosterone, along with a labeled tracer that competes for the same antibodies, and the analyzer turns the tracer's signal into a concentration. For adult men it does a reasonable job. In a study of 3,174 European men, an automated immunoassay caught 75 of every 100 men whose level was low by mass spectrometry, the more precise reference method, and correctly cleared about 96 of every 100 men whose level was not low. In another comparison, more than 60% of automated results in adult men came within 20% of the mass spectrometry value.
Different analyzers often disagree. On samples from the same men, some platforms read about 90 ng/dL low on average and others read nearly 100 ng/dL high, and one research cohort saw reported values jump 11% when it switched manufacturers. A European survey found wide variation in the lab cutoffs used for men, and fewer than half of labs required fasting morning samples.
Accuracy falls off most in people with low levels or unusual blood chemistry. When ten immunoassays were checked against mass spectrometry, none was reliable enough for the very low concentrations found in children and women. The three groups below show how large the errors can get.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| Young men with obesity but no diabetes | Immunoassay against mass spectrometry | The immunoassay labeled about twice as many men as low (53.7% versus 26.3%) |
| Adults on hemodialysis for kidney failure | Automated immunoassays against mass spectrometry | Average errors ran as high as 92%, because the altered blood chemistry confuses the test |
| Children | Routine immunoassays against mass spectrometry | Results ranged from about half the true value to more than double it |
Sources: Martínez-Escribano et al.; Jansen et al.; Ankarberg-Lindgren et al.
What this means for you: if you're an adult man without obesity or kidney failure, an immunoassay result is a reasonable first check. If you're a woman, carry a lot of extra weight, are on dialysis, or are on hormone-blocking treatment for prostate cancer, where immunoassays also fall short near the treatment goal, treat the result as a screen. Confirm it with SHBG and free testosterone, or with a mass spectrometry test.
Doctors call low testosterone plus matching symptoms male hypogonadism. The usual symptoms are low libido, erectile problems, loss of muscle, anemia, and thinning bones. In a Swedish cohort of 657 men, lower total testosterone went with a heavier burden of sexual symptoms, and that held whichever lab method was used.
Neither the symptoms nor the number settles the question alone. The symptoms have many possible causes, and a single reading varies enough that it can mislead you. A diagnosis needs both pieces to agree, which is why a borderline result calls for a second test and a few follow-up tests rather than a prescription.
Large cohort studies keep finding that men with lower testosterone die sooner. In about 149,000 middle-aged and older UK men, lower testosterone went with higher death rates from all causes and from cancer. In the EPIC-Norfolk study in England, men with higher testosterone had lower death rates from heart disease and from all causes. A German cohort of 1,954 men aged 20 to 79 found that low testosterone predicted more deaths, including from heart disease and cancer, and a California study of 794 older men followed for about 20 years found the same even after accounting for standard risk factors and existing illness.
Studies that pool many cohorts are less consistent. A 2024 analysis that combined individual data from many cohorts found higher all-cause mortality in men with low testosterone, and a 2018 meta-analysis concluded low testosterone marks higher cardiovascular risk. A 2021 meta-analysis of community-dwelling men found no significant link with heart disease deaths or overall deaths, and a 2010 analysis found no link in middle-aged men. These cohorts used a mix of lab methods, so their findings tell you which direction risk runs, and their absolute numbers don't carry over to your immunoassay result.
Two more findings help explain the disagreement. In 5,786 middle-aged and older Chinese men, both low and high testosterone went with greater cardiovascular risk, and low testosterone tracked with high blood pressure. A genetic study of 625,650 people couldn't show that testosterone itself causes most of the diseases it's linked to, apart from sex-specific conditions. Taken together, these suggest low testosterone works mainly as a sign of overall health. Obesity, chronic illness, and other problems push it down, so a low number in observational data partly reflects whatever else is going wrong. That's why cohorts link it to earlier death while pooled and genetic analyses can't pin down that the hormone is the cause.
In practice, if your result is low, look for the reason behind it. Check your weight, blood sugar, kidney function, and medications before you assume the testes are the problem, and before you conclude that raising the number will lower your risk.
British sexual medicine guidelines link testosterone deficiency in men with higher rates of type 2 diabetes and chronic kidney disease. Testosterone falls as kidney disease gets more advanced. In 2,419 men with moderate to advanced kidney disease, those with low total testosterone had higher mortality. Genetic evidence suggests the link with diabetes probably runs from poor metabolic health to low testosterone more than the other way around.
Because of these links, the American Urological Association recommends checking testosterone in men with type 2 diabetes, unexplained bone loss, chronic opioid use, past radiation to the testes, or pituitary disease. If you have diabetes or obesity, remember that your SHBG is probably low too. Order SHBG and free testosterone along with the total, because the total alone may overstate how low you are.
Testosterone matters in women for reproduction, bone, muscle, heart health, and brain function, though there isn't one agreed standard range for women. High testosterone is one lab sign used in polycystic ovary syndrome (PCOS), along with symptoms and ovulation pattern. PCOS is a common hormone condition that causes irregular ovulation, excess hair, acne, and fertility problems. Very high levels can point to an androgen-secreting tumor of the ovary or adrenal gland, and immunoassays usually pick up those larger elevations.
For diagnosing PCOS, total testosterone caught about 74 of every 100 women who had it and correctly cleared about 86 of every 100 who didn't, across 23 studies. Direct immunoassays tend to overread women's low levels and vary enough that mass spectrometry is preferred when the result will guide a diagnosis or treatment. In 906 infertile women with PCOS, mass spectrometry did a better job identifying the women at real risk of poor fertility outcomes. If your immunoassay result comes back high, confirm it with mass spectrometry before you act on it.
Testosterone follows a daily rhythm, responds to meals and illness, and depends on SHBG, so when and how your blood is drawn changes the result. These are the most common ways a single reading ends up misleading:
Some medications change the number without meaning your testes are failing:
Testosterone varies a lot within the same person. In healthy men, day-to-day variation runs about 16% to 18.7%. In a group of 121 men sampled within four hours of waking, a man's true average could plausibly fall anywhere from 65% to 153% of any single reading.
That variation has real consequences. Up to half of men labeled low on a first test come back normal on the next one. In the 121-man group, only 40% of men whose first result was clearly low stayed in that category averaged over six visits, and 20% averaged out of the low range. For a change between two morning draws to mean more than normal fluctuation, it has to be larger than about 52%.
So read one result as a starting point. Confirm any low reading with a second fasting draw between 7 and 10 a.m. Get a baseline, retest in 3 to 6 months if you're losing weight, changing medications, or starting treatment, and then test at least once a year. Use the same lab each time, since a change of analyzer alone can shift the number by 11%.
If you're on testosterone therapy, time your draws relative to your dose. With a daily gel, 70% of men had adequate levels 2 hours after applying it but only 36.7% at 23 hours, so draw at the same point in your dosing cycle every time.
Once a second morning draw has confirmed the result, the next step depends on the pattern:
Evidence-backed interventions that affect your Total Testosterone level
Total Testosterone is best interpreted alongside these tests.